HIGHLIGHTS
- who: Yanna Lei et al. from the Stony Brook Medicine, United States University of Nebraska Medical Center have published the paper: gC1qR: A New Target for Cancer Immunotherapy, in the Journal: (JOURNAL)
- what: The authors focus on recent advances in the understanding of gC1qR in cancer, review results supporting the role of gC1qR in cancer immunology and illustrate its potential for translation into clinical practice. chromosome 17p13.3 in humans, and chromosome 11 in mice.
- how: Potential toxicity was also evaluated and the results showed that there was no evidence of tissue damage . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.